The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.
 
Hong Truong
No Relationships to Disclose
 
Kelsey Breen
Stock and Other Ownership Interests - Imago Pharma (I); Isabl Technologies (I)
Consulting or Advisory Role - DarwinHealth (I); Emendo (I); Imago Pharma (I); Karyopharm Therapeutics (I)
Patents, Royalties, Other Intellectual Property - Royalty from licensing agreements with MI Bioresearch (I)
 
Yelena Kemel
No Relationships to Disclose
 
Andrew Thomas Lenis
No Relationships to Disclose
 
Peter Reisz
No Relationships to Disclose
 
Nicole Benfante
No Relationships to Disclose
 
Behfar Ehdaie
No Relationships to Disclose
 
Karim A. Touijer
No Relationships to Disclose
 
Vincent Paul Laudone
No Relationships to Disclose
 
Peter T. Scardino
Patents, Royalties, Other Intellectual Property - 4K Score; OPKO Biotechnology
 
James Andrew Eastham
Stock and Other Ownership Interests - 3D Biopsy
 
Vijai Joseph
No Relationships to Disclose
 
Ozge Birsoy
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Allergan (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Novartis (I); Optos (I); Regeneron (I); Regenxbio (I)
 
Kenneth Offit
No Relationships to Disclose
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Athenex; Bayer; Curium Pharma; Curium Pharma; Endocyte; Johnson & Johnson; ORIC Pharmaceuticals
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Janssen (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Endocyte; Fujifilm
 
Wassim Abida
Honoraria - Aptitude Health; CARET; Medscape; Roche
Consulting or Advisory Role - Clovis Oncology; Daiichi Sankyo; Janssen; MORE Health; ORIC Pharmaceuticals
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); ORIC Pharmaceuticals (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - Clovis Oncology; GlaxoSmithKline; ORIC Pharmaceuticals
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - AstraZeneca (Inst); Merck (Inst); Pfizer (Inst)
Other Relationship - Clinical Care Options; Invitae (Inst); Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Daiichi Sankyo; Epic Sciences; Merck; Pfizer
 
Maria Isabel Carlo
Consulting or Advisory Role - Pfizer
Other Relationship - Prostate Cancer Foundation; Robert Wood Johnson Foundation